QuanDx Announces Distribution Agreement for the Zeesan CE-IVD High Risk HPV Genotyping Assay
November 24, 2015QuanDx Raises $3.0 Million in Series B2 Financing
January 11, 2016See you at AMP annual meeting in Austin, TX
San Francisco, CA, USA. Sept. 24th, 2015 QuanDx Inc., a biotechnology company developing and commercializing innovative molecular diagnostic tests for personalized cancer treatment, welcome you to stop by our Booth (#215) in Austin, TX.